Ledger.Open graph →
SEC Form D · filed February 2, 2016

Brazos Bridge Pharmaceuticals, Inc

Offering
$2.0M
Sold
$300K
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
NAPA, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (3)

Daniel R. Henderson · Napa, CAExec · DirectorCary Davis · San Francisco, CAExec · DirectorDavid J. Egglishaw · George Town, Grand Cayman, Cayman IslandsExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗